NCT03915938View on ClinicalTrials.gov

Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Acute PainChronic Pain, WidespreadSchizophrenia
Interventions
DRUG

Ketamine

S-ketamine will be administered in precalculated infusion rates to obtain a plasmatic level of 60 ng/ml

DRUG

Placebo

Administered in an identical way than ketamine.

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT03915938 - Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain | Biotech Hunter | Biotech Hunter